Skip to Content

AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data

Thrasyvoulos Tzellos presents in this MEDtalk the results from a multinational prospective long-term study that assessed both efficacy and safety for treatment with dupilumab in real-world practice. According to Thrasyvoulos Tzellos, the study’s results are very promising in terms of safety.

Thrasyvoulos Tzellos

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top